Glutathione S-transferase null and cholesteryl ester transfer protein TaqI B polymorphisms and lipid response to atorvastatin in Greek dyslipidaemic patients

Basic and Clinical Pharmacology and Toxicology

Volumn 102, Issue 6, 2008, Pages 559-562

  Goulas, Antonis ^a,b   Kosmidou, Maria ^a   Hatzitolios, Apostolos I ^a   Molyva, Dimitra ^a   Fidani, Liana ^b   Giannopoulos, Sotirios ^c   Mirtsou, Vassiliki ^a  

^a AHEPA UNIVERSITY HOSPITAL   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c UNIVERSITY OF IOANNINA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; CHOLESTEROL ESTER; GLUTATHIONE TRANSFERASE;

ARTICLE; DNA POLYMORPHISM; DYSLIPIDEMIA; GENOTYPE; GREECE; HUMAN; LABORATORY TEST; PRIORITY JOURNAL; TREATMENT RESPONSE;

ANTICHOLESTEREMIC AGENTS; CHOLESTEROL ESTER TRANSFER PROTEINS; FEMALE; GENE SILENCING; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE TRANSFERASE; GREECE; HEPTANOIC ACIDS; HUMANS; HYPERLIPIDEMIAS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PYRROLES; REFERENCE VALUES;

EID: 43749099196     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2008.00220.x     Document Type: Article

References (30)

1. Kontush A, Chapman MJ. Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis. Pharmacol Rev 2006 58 : 342 74.
2. Nicholls SJ, Rye KA, Barter PJ. High-density lipoproteins as therapeutic targets. Curr Opin Lipidol 2005 16 : 345 9.
3. Schaefer EJ, McNamara JR, Tayler T, Daly JA, Gleason JA, Seman LJ et al. Effects of atorvastatin on fasting and postprandial lipoprotein subclasses in coronary heart disease patients versus control subjects. Am J Cardiol 2002 90 : 689 96.
4. Schaefer JR, Schweer H, Ikewaki K, Stracke H, Seyberth HJ, Kaffarnik H et al. Metabolic basis of high density lipoproteins and apolipoprotein A-I increase by HMG-CoA reductase inhibition in healthy subjects and a patient with coronary artery disease. Atherosclerosis 1999 144 : 177 84.
5. Bercovich D, Friedlander Y, Korem S, Huminer A, Hoffman A, Kleinberq L et al. The association of common SNPs and haplotypes in the CETP and MDR1 genes with lipids response to fluvastatin in familial hypercholesterolemia. Atherosclerosis 2006 185 : 97 107.
6. Boekholdt SM, Sacks FM, Jukema JW, Shepherd J, Freeman DJ, McMahon AD et al. Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects. Circulation 2005 111 : 278 87.
7. Fiegenbaum M, da Silveira FR, Van der Sand CR, Van der Sand LC, Ferreira MEW, Pires RC et al. Pharmacogenetic study of apolipoprotein E, cholesteryl ester transfer protein and hepatic lipase genes and simvastatin therapy in Brazilian subjects. Clin Chim Acta 2005 362 : 182 8.
8. Harrison D, Griendling KK, Landmesser U, Hornig B, Drexler H. Role of oxidative stress in atherosclerosis. Am J Cardiol 2003 91 : 7A 11A.
9. Nicholls SJ, Zheng L, Hazen SL. Formation of dysfunctional high-density lipoprotein by myeloperoxidase. Trends Cardiovasc Med 2005 15 : 212 9.
10. Cuthbert C, Wang Z, Zhang X, Tam S-P. Regulation of human apolipoprotein A-I gene expression by gramoxone. J Biol Chem 1997 272 : 14954 60.
11. Liao JK, Laufs U. Pleiotropic effects of statins. Ann Rev Pharmacol Toxicol 2005 45 : 89 118.
12. Bisoendial RJ, Hovingh GK, El Harchaoui K, Levels JHM, Tsimikas S, Pu K et al. Consequences of cholesteryl ester transfer protein inhibition in patients with familial hypoalphalipoproteinemia. Arterioscler Thromb Vasc Biol 2005 25 : e133 4.
13. Nagano M, Yamashita S, Hirano K, Takano M, Maruyama T, Ishihara M et al. Molecular mechanisms of cholesteryl ester transfer protein deficiency in Japanese. J Atheroscler Thromb 2004 11 : 110 21.
14. Zhou H, Li Z, Hojjati MR, Jang D, Beyer TP, Cao G et al. Adipose tissue-specific CETP expression in mice: impact on plasma lipoprotein metabolism. J Lipid Res 2006 47 : 2011 9.
15. Cotton SC, Sharp L, Little J, Brockton N. Glutathione S-transferase polymorphisms and colorectal cancer: a HuGE review. Am J Epidemiol 2000 151 : 7 32.
16. Wilson MH, Grant PJ, Hardie LJ, Wild CP. Glutathione S-transferase M1 null genotype is associated with a decreased risk of myocardial infarction. FASEB J 2000 14 : 791 6.
17. Wilson MH, Grant PJ, Kain K, Warner DP, Wild CP. Association between the risk of coronary artery disease in South Asians and a deletion polymorphism in glutathione S-transferase M1. Biomarkers 2003 8 : 43 50.
18. Hayek T, Stephens JW, Hubbart CS, Acharya J, Caslake MJ, Hawe E et al. A common variant in the glutathione S transferase gene is associated with elevated markers of inflammation and lipid peroxidation in subjects with diabetes mellitus. Atherosclerosis 2006 184 : 404 12.
19. Marinho C, Alho I, Arduino D, Falcao LM, Bras-Nogueira J, Bicho M. GST M1/T1 and MTHFR polymorphisms as risk factors for hypertension. Biochem Biophys Res Commun 2007 353 : 344 50.
20. de Waart FG, Kok FJ, Smilde TJ, Hijmans A, Wollersheim H, Stalenhoef AF. Effect of glutathione S-transferase M1 genotype on progression of atherosclerosis in lifelong male smokers. Atherosclerosis 2001 158 : 227 31.
21. Masetti S, Botto N, Manfredi S, Manfredi S, Colombo MG, Rizza A et al. Interactive effect of the glutathione S-transferase genes and cigarette smoking on occurrence and severity of coronary artery risk. J Mol Med 2003 81 : 488 94.
22. Olshan AF, Li R, Pankow JS, Bray M, Tyroler HA, Chambless LE et al. Risk of atherosclerosis: interaction of smoking and glutathione S-transferase genes. Epidemiology 2003 14 : 321 7.
23. Wang XL, Greco M, Sim AS, Duarte N, Wang J, Wilcken DE. Glutathione S-transferase mu1 null deficiency, cigarette smoking and coronary artery disease. J Cardiovasc Risk 2002 9 : 25 31.
24. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972 18 : 499 502.
25. Joseph T, Chacko P, Wesley R, Jayaprakash PG, James FV, Pillai MR. Germline genetic polymorphisms of CYP1A1, GSTM1 and GSTT1 genes in Indian cervical cancer: associations with tumor progression, age and human papillomavirus infection. Gynecol Oncol 2006 101 : 411 7.
26. Cuchel M, Wolfe ML, de Lemos AS, Rader DJ. The frequency of the cholesteryl ester transfer protein Taq1 B2 allele is lower in African Americans than in Caucasians. Atherosclerosis 2002 163 : 169 74.
27. Guerin M, Lassel TS, Le Goff W, Farnier M, Chapman MJ. Action of atorvastatin in combined hyperlipidemia. Preferential reduction of cholesteryl ester transfer from HDL to VLDL1 particles. Arterioscler Thromb Vasc Biol 2000 20 : 189 97.
28. Jia L, Bai H, Fu M, Xu Y, Yang Y, Long S. Relationship between plasma HDL subclasses distribution and apoA-I gene polymorphisms. Clin Chim Acta 2005 360 : 37 45.
29. Grodzinska L, Starzyk D, Bieron K, Goszcz A, Korbut R. Simvastatin effects in normo- and hypercholesterolaemic patients with peripheral arterial occlusive disease: a pilot study. Basic Clin Pharmacol Toxicol 2005 96 : 413 9.
30. Miller EA, Pankow JS, Millikan RC, Bray MS, Ballantyne CM, Bell DA et al. Glutathione-S-transferase genotypes, smoking, and their association with markers of inflammation, hemostasis, and endothelial function: the atherosclerosis risk in communities (ARIC) study. Atherosclerosis 2003 171 : 265 72.